Celcuity Inc. Announces Concurrent Public Offerings of Convertible Senior Notes Due 2031 and Common Stock
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 28 2025
0mins
Source: Globenewswire
Convertible Notes and Common Stock Offerings: Celcuity Inc. announced proposed public offerings of $150 million in convertible senior notes due 2031 and $75 million in common stock, with options for underwriters to purchase additional amounts to cover over-allotments.
Use of Proceeds and Future Plans: The proceeds from these offerings will be used for capped call transactions, working capital, clinical trial expenditures, and other corporate purposes, while the company continues its development of targeted therapies for oncology, particularly its lead candidate gedatolisib.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
